Lacidipine
ArticlesMedicine Compliance Aid StabilityLactation Safety Information · Published , updated
319299000
Articles
23 September 2020
Safety in Lactation: Drugs for hypertension
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Many of the drugs covered by… Acebutolol Aliskiren Ambrisentan Amlodipine Atenolol Azilsartan Bisoprolol Bosentan Candesartan Captopril Cardiovascular system disorders Carvedilol Celiprolol Cilazapril Clonidine Diazoxide Diltiazem Doxazosin Enalapril Epoprostenol Eprosartan Felodipine Fosinopril Hydralazine Iloprost Imidapril Indoramin Irbesartan Labetalol Lacidipine Lercanidipine Lisinopril Losartan Macitentan Methyldopa Metoprolol Minoxidil Moxonidine Nadolol Nebivolol Nicardipine Nifedipine Nimodipine Olmesartan Oxprenolol Perindopril Phentolamine Pindolol Prazosin Propranolol Ramipril Sacubitril + Valsartan Safety in Breastfeeding Sildenafil Sodium nitroprusside Tadalafil Telmisartan Terazosin Timolol Valsartan Verapamil
1 June 2020
What are the reported incidences of ankle oedema with different calcium channel blockers?
The potential to cause ankle oedema appears to exist for all calcium channel blocking agents, and is caused by increasing capillary pressure leading to leakage… Amlodipine Cardiovascular system disorders Diltiazem Felodipine Isradipine Lacidipine Lercanidipine Nicardipine Nifedipine Nimodipine Verapamil
1 June 2020
How should ankle oedema caused by calcium channel blockers be treated?
Ankle oedema is a common, often troublesome adverse effect for patients who are receiving calcium channel blocker (CCB) therapy, and may affect compliance. It is… Adherence Amlodipine Cardiovascular system disorders Diltiazem Felodipine Furosemide Isradipine Lacidipine Lercanidipine Nicardipine Nifedipine Nimodipine Polypharmacy VerapamilMedicine Compliance Aid Stability
MotensGlaxoSmithKline UK
GlaxoSmithKline UK
Motens
Tablets 2mg, 4mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Light sensitive tablets so protection from light is essential.
9 November 2015
Lactation Safety Information
Nifedipine, Verapamil
No published evidence of safety
Monitor infant for adverse effects
16 January 2017